CSTL FY 2020 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$805M

FY 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$63M+20.8% YoY

Gross Profit

$53M84.5% margin

Operating Income

-$7M-10.4% margin

Net Income

-$10M-16.4% margin

EPS (Diluted)

$-0.54

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$5M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$439M

Total Liabilities

$24M

Stockholders' Equity

$416M

Cash & Equivalents

$410M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$63M	$52M	+20.8%
Gross Profit	$53M	$45M	+18.9%
Operating Income	-$7M	$7M	-189.3%
Net Income	-$10M	$5M	-294.9%